PropertyValue
?:abstract
  • Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic and to help the return to pre-pandemic normalcy. A great many vaccine candidates are being developed, several of which have completed late-stage clinical trials and are reporting positive results. In this Progress article, we discuss which viral elements are used in COVID-19 vaccine candidates, why they might act as good targets for the immune system and the implications for protective immunity.
?:creator
?:doi
?:doi
  • 10.1038/s41577-020-00480-0
?:journal
  • Nat_Rev_Immunol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/e203be81cac480481e1beba574e4f58e9e82303b.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7747004.xml.json
?:pmcid
?:pmid
?:pmid
  • 33340022.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Viral targets for vaccines against COVID-19
?:type
?:year
  • 2020-12-18

Metadata

Anon_0  
expand all